In 2023, Ireland led the European market in the production of medicaments containing alkaloids or derivatives, accounting for the highest share among countries analyzed. Germany followed closely, with France, the United Kingdom, and Italy rounding out the top five. Over the last year, notable growth was observed in Greece and Belgium. Sweden witnessed a significant increase, reflecting an impressive surge in production capacity or demand. Conversely, France, the United Kingdom, and Spain experienced negative growth rates, indicative of potential market challenges or shifts in production focus.
Looking ahead, key trends to monitor include ongoing investment in pharmaceutical innovation, shifts in regulatory environments, and the impact of geopolitical factors such as Brexit on supply chains. Furthermore, sustainable and digital transformation within the pharmaceutical production sector might influence future market dynamics significantly across Europe.
Top countries in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics Share by Country (Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Ireland | 19.49 | 2023 | +6.62% | +8.52% | View data |
| 2 | 2 Germany | 18.41 | 2023 | +1.4% | +0.22% | View data |
| 3 | 3 France | 15.17 | 2023 | +3.42% | -0.9% | View data |
| 4 | 4 United Kingdom | 8.54 | 2023 | -0.51% | -0.55% | View data |
| 5 | 5 Italy | 7.92 | 2023 | +1.7% | +3.08% | View data |
| 6 | 6 Belgium | 7.78 | 2023 | +1.17% | +10.28% | View data |
| 7 | 7 Spain | 6.6 | 2023 | +1.36% | -0.78% | View data |
| 8 | 8 Poland | 2.35 | 2023 | +0.048% | +0.57% | View data |
| 9 | 9 Greece | 1.9 | 2023 | +3.62% | +11.63% | View data |
| 10 | 10 Hungary | 1.89 | 2023 | +1.37% | +2.26% | View data |
